Literature DB >> 30230174

When one becomes many-Alternative splicing in β-cell function and failure.

Maria Inês Alvelos1, Jonàs Juan-Mateu1, Maikel Luis Colli1, Jean-Valéry Turatsinze1, Décio L Eizirik1.   

Abstract

Pancreatic β-cell dysfunction and death are determinant events in type 1 diabetes (T1D), but the molecular mechanisms behind β-cell fate remain poorly understood. Alternative splicing is a post-transcriptional mechanism by which a single gene generates different mRNA and protein isoforms, expanding the transcriptome complexity and enhancing protein diversity. Neuron-specific and certain serine/arginine-rich RNA binding proteins (RBP) are enriched in β-cells, playing crucial roles in the regulation of insulin secretion and β-cell survival. Moreover, alternative exon networks, regulated by inflammation or diabetes susceptibility genes, control key pathways and processes for the correct function and survival of β-cells. The challenge ahead of us is to understand the precise role of alternative splicing regulators and splice variants on β-cell function, dysfunction and death and develop tools to modulate it.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  alternative splicing; candidate genes; pancreatic β-cells; splicing factors; type 1 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30230174      PMCID: PMC6148369          DOI: 10.1111/dom.13388

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  114 in total

Review 1.  MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research.

Authors:  Jonàs Juan-Mateu; Olatz Villate; Décio L Eizirik
Journal:  Eur J Endocrinol       Date:  2015-12-01       Impact factor: 6.664

2.  β-Cell evolution: How the pancreas borrowed from the brain: The shared toolbox of genes expressed by neural and pancreatic endocrine cells may reflect their evolutionary relationship.

Authors:  Margot E Arntfield; Derek van der Kooy
Journal:  Bioessays       Date:  2011-06-16       Impact factor: 4.345

3.  rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data.

Authors:  Shihao Shen; Juw Won Park; Zhi-xiang Lu; Lan Lin; Michael D Henry; Ying Nian Wu; Qing Zhou; Yi Xing
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-05       Impact factor: 11.205

4.  Neuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival.

Authors:  Jonàs Juan-Mateu; Tatiana H Rech; Olatz Villate; Esther Lizarraga-Mollinedo; Anna Wendt; Jean-Valery Turatsinze; Letícia A Brondani; Tarlliza R Nardelli; Tatiane C Nogueira; Jonathan L S Esguerra; Maria Inês Alvelos; Piero Marchetti; Lena Eliasson; Décio L Eizirik
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

Review 5.  Splicing regulation in neurologic disease.

Authors:  Donny D Licatalosi; Robert B Darnell
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

Review 6.  Integrating transcriptome and proteome profiling: Strategies and applications.

Authors:  Dhirendra Kumar; Gourja Bansal; Ankita Narang; Trayambak Basak; Tahseen Abbas; Debasis Dash
Journal:  Proteomics       Date:  2016-08-25       Impact factor: 3.984

7.  Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A.

Authors:  Anna Corrionero; Belén Miñana; Juan Valcárcel
Journal:  Genes Dev       Date:  2011-03-01       Impact factor: 11.361

8.  SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.

Authors:  Ledong Wan; Wenying Yu; Enhui Shen; Wenjie Sun; Yuan Liu; Jianlu Kong; Yihua Wu; Fengyan Han; Lei Zhang; Tianze Yu; Yuwei Zhou; Sunzhe Xie; Enping Xu; Honghe Zhang; Maode Lai
Journal:  Gut       Date:  2017-11-07       Impact factor: 23.059

9.  SplicePie: a novel analytical approach for the detection of alternative, non-sequential and recursive splicing.

Authors:  Irina Pulyakhina; Isabella Gazzoli; Peter A C 't Hoen; Nisha Verwey; Johan T den Dunnen; Annemieke Aartsma-Rus; Jeroen F J Laros
Journal:  Nucleic Acids Res       Date:  2015-10-07       Impact factor: 16.971

10.  REST, a master regulator of neurogenesis, evolved under strong positive selection in humans and in non human primates.

Authors:  Alessandra Mozzi; Franca Rosa Guerini; Diego Forni; Andrea Saul Costa; Raffaello Nemni; Francesca Baglio; Monia Cabinio; Stefania Riva; Chiara Pontremoli; Mario Clerici; Manuela Sironi; Rachele Cagliani
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

View more
  14 in total

1.  The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes.

Authors:  Ernesto S Nakayasu; Wei-Jun Qian; Carmella Evans-Molina; Raghavendra G Mirmira; Decio L Eizirik; Thomas O Metz
Journal:  Expert Rev Proteomics       Date:  2019-06-24       Impact factor: 3.940

2.  Alternative exon splicing and differential expression in pancreatic islets reveals candidate genes and pathways implicated in early diabetes development.

Authors:  Sayeed Ur Rehman; Tanja Schallschmidt; Axel Rasche; Birgit Knebel; Torben Stermann; Delsi Altenhofen; Ralf Herwig; Annette Schürmann; Alexandra Chadt; Hadi Al-Hasani
Journal:  Mamm Genome       Date:  2021-04-20       Impact factor: 2.957

3.  An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells.

Authors:  Maikel L Colli; Mireia Ramos-Rodríguez; Ernesto S Nakayasu; Maria I Alvelos; Miguel Lopes; Jessica L E Hill; Jean-Valery Turatsinze; Alexandra Coomans de Brachène; Mark A Russell; Helena Raurell-Vila; Angela Castela; Jonàs Juan-Mateu; Bobbie-Jo M Webb-Robertson; Lars Krogvold; Knut Dahl-Jorgensen; Lorella Marselli; Piero Marchetti; Sarah J Richardson; Noel G Morgan; Thomas O Metz; Lorenzo Pasquali; Décio L Eizirik
Journal:  Nat Commun       Date:  2020-05-22       Impact factor: 14.919

4.  The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells.

Authors:  Maria Inês Alvelos; Mirko Brüggemann; Fx Reymond Sutandy; Jonàs Juan-Mateu; Maikel Luis Colli; Anke Busch; Miguel Lopes; Ângela Castela; Annemieke Aartsma-Rus; Julian König; Kathi Zarnack; Décio L Eizirik
Journal:  Life Sci Alliance       Date:  2020-12-29

Review 5.  Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).

Authors:  Bart O Roep; Sofia Thomaidou; René van Tienhoven; Arnaud Zaldumbide
Journal:  Nat Rev Endocrinol       Date:  2020-12-08       Impact factor: 43.330

6.  Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis.

Authors:  F Szymczak; M L Colli; M J Mamula; C Evans-Molina; D L Eizirik
Journal:  Sci Adv       Date:  2021-01-06       Impact factor: 14.136

Review 7.  Consequences for Pancreatic β-Cell Identity and Function of Unregulated Transcript Processing.

Authors:  Seyed M Ghiasi; Guy A Rutter
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-08       Impact factor: 6.055

Review 8.  Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing.

Authors:  Stephane Demine; Michael L Schulte; Paul R Territo; Decio L Eizirik
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

9.  Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes.

Authors:  Maikel L Colli; Florian Szymczak; Decio L Eizirik
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-15       Impact factor: 5.555

Review 10.  mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function.

Authors:  Nicole D Moss; Lori Sussel
Journal:  Front Genet       Date:  2020-09-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.